roche glp 1 drug Roche, trailing in obesity, showcases new data for GLP-1 shot RO OFFERS ELI LILLY'S FOUNDAYO™,
Description
Circanas research expects that GLP-1 adoption will grow as the prices of the medicines continue to fall for both the diabetes- and the weightloss-focused medications

Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models.I've been reporting on this space in my #Trends report since March 2024two years ago (Navigating Obesity Care in the Digital Age)

Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it shifts its business from selling compounded weight loss drugs to branded GLP-1 medications.

Honest MindBody GLP-1 review

In this Evidence-based guideline, the authors use a Delphi consensus process to develop uniform guidance for the definition, diagnosis and management of dumping syndrome.

Glucagon-like peptide-1 (GLP-1) receptor is widely distributed in the digestive system, cardiovascular system, adipose tissue and central nervous system
